speb/financial-data huggingface dataset:
GP balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 12924740.00
GP income_statement (annual, 2023-03-31) — General And Administrative Expense: 16312277.00
GP balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 10546276.00
GP balance_sheet (annual, 2023-03-31) — Gross PPE: 11291558.00
GP income_statement (annual, 2023-03-31) — Gross Profit: 7250054.00
GP income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 250832.00
GP income_statement (annual, 2023-03-31) — Insurance And Claims: 1801665.00
GP income_statement (annual, 2023-03-31) — Interest Expense: 1549769.00
GP income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1549769.00
GP balance_sheet (annual, 2023-03-31) — Inventory: 41609234.00
GP balance_sheet (annual, 2023-03-31) — Invested Capital: 38172101.00
GP cash_flow (annual, 2023-03-31) — Investing Cash Flow: 303191.00
GP cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 4895826.00
GP cash_flow (annual, 2023-03-31) — Issuance Of Debt: 3904642.00
GP balance_sheet (annual, 2023-03-31) — Land And Improvements: 0.00
GP balance_sheet (annual, 2023-03-31) — Leases: 163979.00
GP balance_sheet (annual, 2023-03-31) — Line Of Credit: 6612232.00
GP balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 4570811.00
GP balance_sheet (annual, 2023-03-31) — Long Term Debt: 608751.00
GP balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 5179562.00
GP cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 3058789.00
GP cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -394580.00
GP balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3660540.00
GP cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -215000.00
GP cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 4895826.00
GP balance_sheet (annual, 2023-03-31) — Net Debt: 9909693.00
GP cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 30897.00
GP income_statement (annual, 2023-03-31) — Net Income: -15043857.00
GP income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -15043857.00
GP income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -15043857.00
GP income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -15043857.00
GP income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -15043857.00
GP cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -15043857.00
GP income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -15043857.00
GP income_statement (annual, 2023-03-31) — Net Interest Income: -1549769.00
GP cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 3510062.00
GP cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 2664209.00
GP income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1549769.00
GP cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -225369.00
GP balance_sheet (annual, 2023-03-31) — Net PPE: 7450529.00
GP cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 518191.00
GP cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 845853.00
GP balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 27662006.00
GP balance_sheet (annual, 2023-03-31) — Non Current Accounts Receivable: 1918483.00
GP balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 2606807.00
GP balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 1938840.00
GP income_statement (annual, 2023-03-31) — Normalized EBITDA: -11993136.00
GP income_statement (annual, 2023-03-31) — Normalized Income: -14838194.83
GP balance_sheet (annual, 2023-03-31) — Notes Receivable: 159171.00
GP cash_flow (annual, 2023-03-31) — Operating Cash Flow: -14437939.00
GP cash_flow (annual, 2023-03-31) — Operating Gains Losses: 30897.00
GP income_statement (annual, 2023-03-31) — Operating Income: -13285226.00
GP income_statement (annual, 2023-03-31) — Operating Revenue: 39695890.00
GP balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 24716628.00
GP balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 3289112.00
GP balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 535484.00
GP balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 12924740.00
GP income_statement (annual, 2023-03-31) — Other Gand A: 3470634.00
GP income_statement (annual, 2023-03-31) — Other Income Expense: -208862.00
GP cash_flow (annual, 2023-03-31) — Other Non Cash Items: 753717.00
GP balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1.00
GP balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 34265.00
GP income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 72867.00
GP income_statement (annual, 2023-03-31) — Other Operating Expenses: 1245241.00
GP balance_sheet (annual, 2023-03-31) — Other Properties: 7467039.00
GP balance_sheet (annual, 2023-03-31) — Other Receivables: 1051873.00
GP balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 7316267.00
GP balance_sheet (annual, 2023-03-31) — Prepaid Assets: 328584.00
GP income_statement (annual, 2023-03-31) — Pretax Income: -15043857.00
GP cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 8761.00
GP balance_sheet (annual, 2023-03-31) — Properties: 0.00
GP income_statement (annual, 2023-03-31) — Provision For Doubtful Accounts: 95153.00
GP cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 95153.00
GP cash_flow (annual, 2023-03-31) — Purchase Of Business: -215000.00
GP cash_flow (annual, 2023-03-31) — Purchase Of PPE: -355993.00
GP balance_sheet (annual, 2023-03-31) — Raw Materials: 5711648.00
GP balance_sheet (annual, 2023-03-31) — Receivables: 11617950.00
GP income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 32445836.00
GP income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1219223.00
GP income_statement (annual, 2023-03-31) — Rent And Landing Fees: 748299.00
GP income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 748299.00
GP cash_flow (annual, 2023-03-31) — Repayment Of Debt: -394580.00
GP income_statement (annual, 2023-03-31) — Research And Development: 2090338.00
GP balance_sheet (annual, 2023-03-31) — Retained Earnings: -60790972.00
GP income_statement (annual, 2023-03-31) — Salaries And Wages: 11039978.00
GP cash_flow (annual, 2023-03-31) — Sale Of PPE: 874184.00
GP income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 818289.00
GP income_statement (annual, 2023-03-31) — Selling General And Administration: 17130566.00
GP balance_sheet (annual, 2023-03-31) — Share Issued: 2471662.00
GP cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 845853.00
GP cash_flow (annual, 2023-03-31) — Short Term Debt Payments: 0.00
GP income_statement (annual, 2023-03-31) — Special Income Charges: -250832.00
GP cash_flow (annual, 2023-03-31) — Stock Based Compensation: 3645893.00
GP balance_sheet (annual, 2023-03-31) — Stockholders Equity: 27662006.00
GP balance_sheet (annual, 2023-03-31) — Tangible Book Value: 27662006.00
GP income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -76066.83
GP income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.27
GP balance_sheet (annual, 2023-03-31) — Taxes Receivable: 133530.00
GP balance_sheet (annual, 2023-03-31) — Total Assets: 63525183.00
GP balance_sheet (annual, 2023-03-31) — Total Capitalization: 28270757.00
GP balance_sheet (annual, 2023-03-31) — Total Debt: 15749946.00
GP balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 27662006.00
GP income_statement (annual, 2023-03-31) — Total Expenses: 52981116.00
GP balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 35863177.00
GP balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 9369013.00
GP balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 9362899.00
GP income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -13285226.00
GP income_statement (annual, 2023-03-31) — Total Unusual Items: -281729.00
GP income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -281729.00
GP balance_sheet (annual, 2023-03-31) — Work In Process: 4025826.00
GP balance_sheet (annual, 2023-03-31) — Working Capital: 27655892.00
GP income_statement (annual, 2024-03-31) — +Operating Expense: 22159977.00
GP income_statement (annual, 2024-03-31) — +Total Revenue: 39271839.00
GP balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2831942.00
GP balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5131619.00
GP balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -1459243.00
GP cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 1502121.00
GP income_statement (annual, 2024-03-31) — Basic Average Shares: 24950961.00
GP income_statement (annual, 2024-03-31) — Basic EPS: -7.35
GP cash_flow (annual, 2024-03-31) — Beginning Cash Position: 600402.00
GP cash_flow (annual, 2024-03-31) — Capital Expenditure: -361533.00
GP balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 4636211.00
GP balance_sheet (annual, 2024-03-31) — Capital Stock: 76393993.00
GP balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1150891.00
GP balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1150891.00
GP balance_sheet (annual, 2024-03-31) — Cash Financial: 1150891.00
GP cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 2323833.00
GP cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -761533.00
GP cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: -1132248.00
GP cash_flow (annual, 2024-03-31) — Change In Account Payable: -4339016.00
GP cash_flow (annual, 2024-03-31) — Change In Inventory: 8752609.00
GP cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 571570.00
GP cash_flow (annual, 2024-03-31) — Change In Other Working Capital: -337484.00
GP cash_flow (annual, 2024-03-31) — Change In Payable: -4339016.00
GP cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: -4339016.00
GP cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: -419778.00
GP cash_flow (annual, 2024-03-31) — Change In Receivables: 6387229.00
GP cash_flow (annual, 2024-03-31) — Change In Working Capital: 10615130.00
GP cash_flow (annual, 2024-03-31) — Changes In Account Receivables: 6255091.00
GP cash_flow (annual, 2024-03-31) — Changes In Cash: 430052.00
GP balance_sheet (annual, 2024-03-31) — Common Stock: 76393993.00
GP balance_sheet (annual, 2024-03-31) — Common Stock Equity: 11566819.00
GP cash_flow (annual, 2024-03-31) — Common Stock Issuance: 520892.00
GP income_statement (annual, 2024-03-31) — Cost Of Revenue: 33914237.00
GP balance_sheet (annual, 2024-03-31) — Current Assets: 36853355.00
GP balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 630207.00
GP balance_sheet (annual, 2024-03-31) — Current Debt: 9731103.00
GP balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 10361310.00
GP balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 7066145.00
GP balance_sheet (annual, 2024-03-31) — Current Deferred Revenue: 7066145.00
GP balance_sheet (annual, 2024-03-31) — Current Liabilities: 21291590.00
GP cash_flow (annual, 2024-03-31) — Deferred Income Tax: 0.00
GP cash_flow (annual, 2024-03-31) — Deferred Tax: 0.00
GP cash_flow (annual, 2024-03-31) — Depreciation: 1854728.00
GP cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 1854728.00
GP income_statement (annual, 2024-03-31) — Depreciation Amortization Depletion Income Statement: 1858458.00
GP cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1854728.00
GP income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1858458.00
GP income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1858458.00
GP balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 1749084.00
GP income_statement (annual, 2024-03-31) — Diluted Average Shares: 2495096.00
GP income_statement (annual, 2024-03-31) — Diluted EPS: -7.35
GP income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -18342796.00
GP income_statement (annual, 2024-03-31) — EBIT: -16787938.00
GP income_statement (annual, 2024-03-31) — EBITDA: -14929480.00
GP cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 120437.00
GP cash_flow (annual, 2024-03-31) — End Cash Position: 1150891.00
GP cash_flow (annual, 2024-03-31) — Financing Cash Flow: 2323833.00
GP balance_sheet (annual, 2024-03-31) — Finished Goods: 13813014.00
GP cash_flow (annual, 2024-03-31) — Free Cash Flow: -1493781.00
GP cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 0.00
GP income_statement (annual, 2024-03-31) — Gain On Sale Of Ppe: 0.00
GP income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 131416.00
GP balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 14193746.00
GP income_statement (annual, 2024-03-31) — General And Administrative Expense: 16377659.00
GP balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 4291185.00
GP balance_sheet (annual, 2024-03-31) — Gross PPE: 12019707.00
GP income_statement (annual, 2024-03-31) — Gross Profit: 5357602.00
GP income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 423267.00
GP income_statement (annual, 2024-03-31) — Insurance And Claims: 1716157.00
GP income_statement (annual, 2024-03-31) — Interest Expense: 1554858.00
GP income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1554858.00
GP balance_sheet (annual, 2024-03-31) — Inventory: 32010631.00
GP balance_sheet (annual, 2024-03-31) — Invested Capital: 23730102.00
GP cash_flow (annual, 2024-03-31) — Investing Cash Flow: -761533.00
GP cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 520892.00
GP cash_flow (annual, 2024-03-31) — Issuance Of Debt: 3116460.00
GP balance_sheet (annual, 2024-03-31) — Land And Improvements: 0.00
GP balance_sheet (annual, 2024-03-31) — Leases: 190937.00
GP balance_sheet (annual, 2024-03-31) — Line Of Credit: 9731103.00
GP balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 4006004.00
GP balance_sheet (annual, 2024-03-31) — Long Term Debt: 2432180.00
GP balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 6438184.00
GP cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 2265486.00
GP cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1508577.00
GP balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 4534818.00
GP cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
GP cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 520892.00
GP balance_sheet (annual, 2024-03-31) — Net Debt: 11012392.00
GP cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -131416.00
GP income_statement (annual, 2024-03-31) — Net Income: -18342796.00
GP income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -18342796.00
GP income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -18342796.00
GP income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -18342796.00
GP income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -18342796.00
GP cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -18342796.00
GP income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -18342796.00
GP income_statement (annual, 2024-03-31) — Net Interest Income: -1554858.00
GP cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 1607883.00
GP cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 756909.00
GP income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -1554858.00
GP cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -14904.00
GP cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -400000.00
GP balance_sheet (annual, 2024-03-31) — Net PPE: 6888088.00
GP cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -361533.00
GP cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 850974.00
GP balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 11566819.00
GP balance_sheet (annual, 2024-03-31) — Non Current Accounts Receivable: 1046855.00
GP balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 2876240.00
GP balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 2876240.00
GP income_statement (annual, 2024-03-31) — Normalized EBITDA: -14637629.00
GP income_statement (annual, 2024-03-31) — Normalized Income: -18129744.77
GP balance_sheet (annual, 2024-03-31) — Notes Receivable: 0.00
GP cash_flow (annual, 2024-03-31) — Operating Cash Flow: -1132248.00
GP cash_flow (annual, 2024-03-31) — Operating Gains Losses: -131416.00
GP income_statement (annual, 2024-03-31) — Operating Income: -16802375.00
GP income_statement (annual, 2024-03-31) — Operating Revenue: 39271839.00
GP balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 24991162.00
GP balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 886884.00
GP balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 14193746.00
GP income_statement (annual, 2024-03-31) — Other Gand A: 4344829.00
GP income_statement (annual, 2024-03-31) — Other Income Expense: 14437.00
GP cash_flow (annual, 2024-03-31) — Other Non Cash Items: 416911.00
GP balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 414986.00
GP balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 1281367.00
GP income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 306288.00
GP balance_sheet (annual, 2024-03-31) — Other Properties: 7293952.00
GP balance_sheet (annual, 2024-03-31) — Other Receivables: 111529.00
GP balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 2977251.00
GP balance_sheet (annual, 2024-03-31) — Prepaid Assets: 748362.00
GP income_statement (annual, 2024-03-31) — Pretax Income: -18342796.00
GP cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 209962.00
GP balance_sheet (annual, 2024-03-31) — Properties: 0.00
GP income_statement (annual, 2024-03-31) — Provision For Doubtful Accounts: 1450962.00
GP cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 1450962.00
GP cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
GP cash_flow (annual, 2024-03-31) — Purchase Of PPE: -361533.00
GP balance_sheet (annual, 2024-03-31) — Raw Materials: 3855668.00
GP balance_sheet (annual, 2024-03-31) — Receivables: 2943471.00
GP income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 33917967.00
GP income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1854728.00
GP cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1508577.00
GP income_statement (annual, 2024-03-31) — Research And Development: 1811472.00
GP balance_sheet (annual, 2024-03-31) — Retained Earnings: -79020920.00
GP income_statement (annual, 2024-03-31) — Salaries And Wages: 10316673.00
GP cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
GP income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 661426.00
GP income_statement (annual, 2024-03-31) — Selling General And Administration: 17039085.00
GP balance_sheet (annual, 2024-03-31) — Share Issued: 2499116.00
GP cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 850974.00
GP income_statement (annual, 2024-03-31) — Special Income Charges: -423267.00
GP cash_flow (annual, 2024-03-31) — Stock Based Compensation: 1502112.00
GP balance_sheet (annual, 2024-03-31) — Stockholders Equity: 11566819.00
GP balance_sheet (annual, 2024-03-31) — Tangible Book Value: 11566819.00
GP income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -78799.77
GP income_statement (annual, 2024-03-31) — Tax Provision: 0.00
GP income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.27
GP balance_sheet (annual, 2024-03-31) — Total Assets: 45203284.00
GP balance_sheet (annual, 2024-03-31) — Total Capitalization: 13998999.00
GP balance_sheet (annual, 2024-03-31) — Total Debt: 16799494.00
GP balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 11566819.00
GP income_statement (annual, 2024-03-31) — Total Expenses: 56074214.00
GP balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 33636465.00
GP balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 8349929.00
GP balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 12344875.00
GP income_statement (annual, 2024-03-31) — Total Operating Income As Reported: -17919529.00
GP income_statement (annual, 2024-03-31) — Total Unusual Items: -291851.00
GP income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -291851.00
GP balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
GP balance_sheet (annual, 2024-03-31) — Work In Process: 14341949.00
GP balance_sheet (annual, 2024-03-31) — Working Capital: 15561765.00
GP income_statement (quarterly, 2024-09-30) — Basic Average Shares: 26491162.00
GP income_statement (quarterly, 2024-09-30) — Basic EPS: -1.77
GP cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -30493.00
GP income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 26491162.00
GP income_statement (quarterly, 2024-09-30) — Diluted EPS: -1.77
GP income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
GP cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 405878.00
GP cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 909970.00
GP income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
GP income_statement (quarterly, 2024-12-31) — +Operating Expense: 5234644.00
GP income_statement (quarterly, 2024-12-31) — +Total Revenue: 7218897.00
GP balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 1790569.00
GP balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1027861.00
GP cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
GP income_statement (quarterly, 2024-12-31) — Basic Average Shares: 2851290.00
GP income_statement (quarterly, 2024-12-31) — Basic EPS: -1.66
GP cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 116908.00
GP cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -3748.00
GP balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 3986283.00
GP balance_sheet (quarterly, 2024-12-31) — Capital Stock: 80538262.00
GP balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 621086.00
GP balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 621086.00
GP balance_sheet (quarterly, 2024-12-31) — Cash Financial: 621086.00
GP cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1442803.00
GP cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -3748.00
GP cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -1065213.00
GP cash_flow (quarterly, 2024-12-31) — Change In Inventory: 3220975.00
GP cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 166571.00
GP cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 743862.00
GP cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 551297.00
GP cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: -627492.00
GP cash_flow (quarterly, 2024-12-31) — Change In Receivables: -1074970.00
GP cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 2980243.00
GP cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -1089345.00
GP cash_flow (quarterly, 2024-12-31) — Changes In Cash: 373842.00
GP balance_sheet (quarterly, 2024-12-31) — Common Stock: 80538262.00
GP balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 2138161.00
GP cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 2920145.00
GP income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 6164860.00
GP balance_sheet (quarterly, 2024-12-31) — Current Assets: 31635979.00
GP balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 258899.00
GP balance_sheet (quarterly, 2024-12-31) — Current Debt: 10760296.00
GP balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 11019195.00
GP balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 3984687.00
GP balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 3984687.00
GP balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 18800396.00
GP cash_flow (quarterly, 2024-12-31) — Depreciation: 399440.00
GP cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 399440.00
GP income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 399440.00
GP cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 399440.00
GP income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 399440.00
GP income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 399440.00
GP balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 1762544.00
GP income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 28512901.00
GP income_statement (quarterly, 2024-12-31) — Diluted EPS: -1.66
GP income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -4739022.00
GP income_statement (quarterly, 2024-12-31) — EBIT: -4176662.00
GP income_statement (quarterly, 2024-12-31) — EBITDA: -3777222.00
GP cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 130336.00
GP cash_flow (quarterly, 2024-12-31) — End Cash Position: 621086.00
GP cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 1442803.00
GP balance_sheet (quarterly, 2024-12-31) — Finished Goods: 10769067.00
GP cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -1068961.00
GP cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
GP income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
GP income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 3945.00
GP balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 15197266.00
GP income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 4084794.00
GP balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 2818430.00
GP balance_sheet (quarterly, 2024-12-31) — Gross PPE: 5198624.00
GP income_statement (quarterly, 2024-12-31) — Gross Profit: 1054037.00
GP income_statement (quarterly, 2024-12-31) — Insurance And Claims: 397936.00
GP income_statement (quarterly, 2024-12-31) — Interest Expense: 562360.00
GP income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 562360.00
GP balance_sheet (quarterly, 2024-12-31) — Inventory: 28167070.00
GP balance_sheet (quarterly, 2024-12-31) — Invested Capital: 15567165.00
GP cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -3748.00
GP cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 2920145.00
GP cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: -5266.00
GP balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 9664876.00
GP balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 3727384.00
GP balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 2668708.00
GP balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 6396092.00
GP cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: -5266.00
GP cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -1068597.00
GP cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 2920145.00
GP balance_sheet (quarterly, 2024-12-31) — Net Debt: 12807918.00
GP cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -3945.00
GP income_statement (quarterly, 2024-12-31) — Net Income: -4739022.00
GP income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -4739022.00
GP income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -4739022.00
GP income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -4739022.00
GP income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -4739022.00
GP cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -4739022.00
GP income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -4739022.00
GP income_statement (quarterly, 2024-12-31) — Net Interest Income: -562360.00
GP cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -1073863.00
GP cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -1073863.00
GP income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -562360.00
GP cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -483434.00
GP balance_sheet (quarterly, 2024-12-31) — Net PPE: 5198624.00
GP cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -3748.00
GP cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: -1448054.00
GP balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 2138161.00
GP balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 102677.00
GP balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 6858820.00
GP balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 6858820.00
GP income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -3781167.00
GP income_statement (quarterly, 2024-12-31) — Normalized Income: -4742967.00
GP cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -1065213.00
GP cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -3945.00
GP income_statement (quarterly, 2024-12-31) — Operating Income: -4180607.00
GP income_statement (quarterly, 2024-12-31) — Operating Revenue: 7218897.00
GP balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 2949116.00
GP balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 1095420.00
GP balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 774378.00
GP balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 15197266.00
GP income_statement (quarterly, 2024-12-31) — Other Gand A: 630763.00
GP income_statement (quarterly, 2024-12-31) — Other Income Expense: 3945.00
GP cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -78002.00
GP balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 429753.00
GP balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 1411020.00
GP balance_sheet (quarterly, 2024-12-31) — Other Properties: 5198624.00
GP balance_sheet (quarterly, 2024-12-31) — Other Receivables: 45893.00
GP balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 3022136.00
GP balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1011361.00
GP income_statement (quarterly, 2024-12-31) — Pretax Income: -4739022.00
GP cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 79955.00
GP income_statement (quarterly, 2024-12-31) — Provision For Doubtful Accounts: 240396.00
GP cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 240396.00
GP cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -3748.00
GP balance_sheet (quarterly, 2024-12-31) — Raw Materials: 4307870.00
GP balance_sheet (quarterly, 2024-12-31) — Receivables: 1836462.00
GP income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 6164860.00
GP income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 399440.00
GP cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -1068597.00
GP income_statement (quarterly, 2024-12-31) — Research And Development: 380293.00
GP balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -93597367.00
GP income_statement (quarterly, 2024-12-31) — Salaries And Wages: 3056095.00
GP income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 129721.00
GP income_statement (quarterly, 2024-12-31) — Selling General And Administration: 4214515.00
GP balance_sheet (quarterly, 2024-12-31) — Share Issued: 29491162.00
GP cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: -335391.00
GP cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: -1112663.00
GP income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
GP cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 135677.00
GP balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 2138161.00
GP balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 2138161.00
GP income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
GP income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
GP balance_sheet (quarterly, 2024-12-31) — Total Assets: 37367033.00
GP balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 4806869.00
GP balance_sheet (quarterly, 2024-12-31) — Total Debt: 17415287.00
GP balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 2138161.00
GP income_statement (quarterly, 2024-12-31) — Total Expenses: 11399504.00
GP balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 35228872.00
GP balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 5731054.00
GP balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 16428476.00
GP income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -4180607.00
GP income_statement (quarterly, 2024-12-31) — Total Unusual Items: 3945.00
GP income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 3945.00
GP balance_sheet (quarterly, 2024-12-31) — Work In Process: 13090133.00
GP balance_sheet (quarterly, 2024-12-31) — Working Capital: 12835583.00
GP income_statement (quarterly, 2024-12-31) — Write Off: 0.00
GP income_statement (annual, 2025-03-31) — +Operating Expense: 20116132.00
GP income_statement (quarterly, 2025-03-31) — +Operating Expense: 5169826.00
GP income_statement (annual, 2025-03-31) — +Total Revenue: 19847279.00
GP income_statement (quarterly, 2025-03-31) — +Total Revenue: 4284134.00
GP balance_sheet (annual, 2025-03-31) — Accounts Receivable: 541793.00
GP balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 541793.00
GP balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5347760.00
GP balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5347760.00
GP balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -563152.00
GP balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -563152.00
GP cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 0.00
GP cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
GP income_statement (annual, 2025-03-31) — Basic Average Shares: 27580203.00
GP income_statement (annual, 2025-03-31) — Basic EPS: -6.77
GP cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1150891.00
GP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 621086.00
GP cash_flow (annual, 2025-03-31) — Capital Expenditure: -83172.00
GP cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3039.00
GP balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 6168086.00
GP balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 6168086.00
GP balance_sheet (annual, 2025-03-31) — Capital Stock: 80538262.00
GP balance_sheet (quarterly, 2025-03-31) — Capital Stock: 80538262.00
GP balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 344244.00
GP balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 344244.00
GP balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 344244.00
GP balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 344244.00
GP balance_sheet (annual, 2025-03-31) — Cash Financial: 344244.00
GP balance_sheet (quarterly, 2025-03-31) — Cash Financial: 344244.00
GP cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 5100272.00
GP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 134044.00
GP cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -83172.00
GP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -3039.00
GP cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: -5988173.00
GP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -387809.00
GP cash_flow (annual, 2025-03-31) — Change In Account Payable: 581983.00
GP cash_flow (annual, 2025-03-31) — Change In Inventory: 7883289.00
GP cash_flow (quarterly, 2025-03-31) — Change In Inventory: 2867564.00
GP cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 465539.00
GP cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 338507.00
GP cash_flow (annual, 2025-03-31) — Change In Other Working Capital: 46063.00
GP cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -705151.00
GP cash_flow (annual, 2025-03-31) — Change In Payable: 581983.00
GP cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 581983.00
GP cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 567185.00
GP cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: -493308.00
GP cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -230309.00
GP cash_flow (annual, 2025-03-31) — Change In Receivables: 2352656.00
GP cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1394713.00
GP cash_flow (annual, 2025-03-31) — Change In Working Capital: 10836222.00
GP cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 4232509.00
GP cash_flow (annual, 2025-03-31) — Changes In Account Receivables: 2302426.00
GP cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1383071.00
GP cash_flow (annual, 2025-03-31) — Changes In Cash: -971073.00
GP cash_flow (quarterly, 2025-03-31) — Changes In Cash: -256804.00
GP balance_sheet (annual, 2025-03-31) — Common Stock: 80538262.00
GP balance_sheet (quarterly, 2025-03-31) — Common Stock: 80538262.00
GP balance_sheet (annual, 2025-03-31) — Common Stock Equity: -1605966.00
GP balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -1605966.00
GP cash_flow (annual, 2025-03-31) — Common Stock Issuance: 5325850.00
GP cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
GP income_statement (annual, 2025-03-31) — Cost Of Revenue: 17650661.00
GP income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3823052.00
GP balance_sheet (annual, 2025-03-31) — Current Assets: 27775068.00
GP balance_sheet (quarterly, 2025-03-31) — Current Assets: 27775068.00
GP balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 633035.00
GP balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 633035.00
GP balance_sheet (annual, 2025-03-31) — Current Debt: 10909646.00
GP balance_sheet (quarterly, 2025-03-31) — Current Debt: 10909646.00
GP balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 11542681.00
GP balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 11542681.00
GP balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 3279536.00
GP balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 3279536.00
GP balance_sheet (annual, 2025-03-31) — Current Deferred Revenue: 3279536.00
GP balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3279536.00
GP balance_sheet (annual, 2025-03-31) — Current Liabilities: 19668259.00
GP balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19668259.00
GP cash_flow (annual, 2025-03-31) — Deferred Income Tax: 0.00
GP cash_flow (annual, 2025-03-31) — Deferred Tax: 0.00
GP cash_flow (annual, 2025-03-31) — Depreciation: 1662113.00
GP cash_flow (quarterly, 2025-03-31) — Depreciation: 376937.00
GP cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 1662113.00
GP cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 376937.00
GP income_statement (annual, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 1662113.00
GP income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 376937.00
GP cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1662113.00
GP cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 376937.00
GP income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1662113.00
GP income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 376937.00
GP income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1662113.00
GP income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 376937.00
GP balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 1749103.00
GP balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 1749103.00
GP income_statement (annual, 2025-03-31) — Diluted Average Shares: 2758020.00
GP income_statement (annual, 2025-03-31) — Diluted EPS: -6.77
GP income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -3833914.00
GP income_statement (annual, 2025-03-31) — EBIT: -16487111.00
GP income_statement (quarterly, 2025-03-31) — EBIT: -3315162.00
GP income_statement (annual, 2025-03-31) — EBITDA: -14824998.00
GP income_statement (quarterly, 2025-03-31) — EBITDA: -2938225.00
GP cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 164426.00
GP cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -20038.00
GP cash_flow (annual, 2025-03-31) — End Cash Position: 344244.00
GP cash_flow (quarterly, 2025-03-31) — End Cash Position: 344244.00
GP cash_flow (annual, 2025-03-31) — Financing Cash Flow: 5100272.00
GP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 134044.00
GP balance_sheet (annual, 2025-03-31) — Finished Goods: 10110736.00
GP balance_sheet (quarterly, 2025-03-31) — Finished Goods: 10110736.00
GP cash_flow (annual, 2025-03-31) — Free Cash Flow: -6071345.00
GP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -390848.00
GP cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
GP income_statement (annual, 2025-03-31) — Gain On Sale Of Ppe: 0.00
GP income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 40657.00
GP income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1836.00
GP balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 15279279.00
GP balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 15279279.00
GP income_statement (annual, 2025-03-31) — General And Administrative Expense: 16129324.00
GP income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4519597.00
GP balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1104945.00
GP balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1104945.00
GP balance_sheet (annual, 2025-03-31) — Gross PPE: 12137897.00
GP balance_sheet (quarterly, 2025-03-31) — Gross PPE: 12137897.00
GP income_statement (annual, 2025-03-31) — Gross Profit: 2196618.00
GP income_statement (quarterly, 2025-03-31) — Gross Profit: 461082.00
GP income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 0.00
GP income_statement (annual, 2025-03-31) — Insurance And Claims: 1727831.00
GP income_statement (quarterly, 2025-03-31) — Insurance And Claims: 480385.00
GP income_statement (annual, 2025-03-31) — Interest Expense: 2176337.00
GP income_statement (quarterly, 2025-03-31) — Interest Expense: 518752.00
GP income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 2176337.00
GP income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 518752.00
GP balance_sheet (annual, 2025-03-31) — Inventory: 25601888.00
GP balance_sheet (quarterly, 2025-03-31) — Inventory: 25601888.00
GP balance_sheet (annual, 2025-03-31) — Invested Capital: 12153005.00
GP balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12153005.00
GP cash_flow (annual, 2025-03-31) — Investing Cash Flow: -83172.00
GP cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -3039.00
GP cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 5325850.00
GP cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
GP cash_flow (annual, 2025-03-31) — Issuance Of Debt: 2700749.00
GP cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 70056.00
GP balance_sheet (annual, 2025-03-31) — Leases: 193937.00
GP balance_sheet (quarterly, 2025-03-31) — Leases: 193937.00
GP balance_sheet (annual, 2025-03-31) — Line Of Credit: 9574926.00
GP balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 9574926.00
GP balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 5535051.00
GP balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 5535051.00
GP balance_sheet (annual, 2025-03-31) — Long Term Debt: 2849325.00
GP balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2849325.00
GP balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 8384376.00
GP balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 8384376.00
GP cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 2700749.00
GP cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 70056.00
GP cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -562485.00
GP cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 1552189.00
GP balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3948778.00
GP balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3948778.00
GP cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
GP cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 5325850.00
GP cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
GP balance_sheet (annual, 2025-03-31) — Net Debt: 13414727.00
GP balance_sheet (quarterly, 2025-03-31) — Net Debt: 13414727.00
GP cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -40657.00
GP cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -1836.00
GP income_statement (annual, 2025-03-31) — Net Income: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Net Income: -3833914.00
GP income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -3833914.00
GP income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3833914.00
GP income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3833914.00
GP income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3833914.00
GP cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -18663448.00
GP cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3833914.00
GP income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -18663448.00
GP income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3833914.00
GP income_statement (annual, 2025-03-31) — Net Interest Income: -2176337.00
GP income_statement (quarterly, 2025-03-31) — Net Interest Income: -518752.00
GP cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 658630.00
GP cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 142611.00
GP cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 2138264.00
GP cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 1622245.00
GP income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -2176337.00
GP income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -518752.00